There is an analysis from the BMJ after the EMA leaked papers, which consist of pictures, PDFs and docs. I’ll also post it here where you can view. INVESTIGATION – The EMA covid-19 data leak, and what it tells us about mRNA instability PDF

Rapporteur Rolling Review Report Overview LoQ – COVID-19 mRNA Vaccine BioNTech

Rapporteur’s Rolling Review Report New Active Substance Status – COVID-19 mRNA Vaccine BioNTec

Rapporteur’s Rolling Review Report Quality – COVID-19 mRNA Vaccine BioNTec

BNT CMC Peer Reviewer Comparability

COVID-19 mRNA Vaccine BioNTech – EMA peer review comments

INX100434736_AnalyticalMethodTransferBNT162b2-DPMethods

Peer Reviewers Comments_NO 23.11.2020

2020 11 30 – Priority OCs to company

Priority OCs in quality LoQ – COVID-19 mRNA Vaccine BioNTech

20201126_BNT162b2_EMAmeeting_final

Annex 1 – Draft 3.2.P.2.2 Drug Product

Annex 2 – VAL100130986 + attachment_All approved

Annex 3 – BNT162b2 Manufacturing Equipment and Scale

Annex 4 – BNT162b2 CMC Data Timelines_for Pre-sub Meeting_PPQ

M1 20 Nov 2020 FDA Query Responses

M3 20 Nov 2020 FDA Query Responses

COVID-19 mRNA Vaccine BioNTech – CHMP Opinion

COVID-19 mRNA Vaccine BioNTech – CHMP Overview and LoQ

Written procedure for COVID-19.mRNA.Vaccine.BioNTech-5735 for your comments by 3011 1700 CET

Agenda for ETF meeting on COVID-19 vaccines – 26 November 2020

BWP report BioNTech mRNA COVID19 vaccine- Adopted

COVID-19 vaccine (recombinant, adjuvanted) Draft joint report as agreed by Rapps

Summary of the ETF meeting on COVID-19 vaccine – 26 November 2020

British Medical Journal Analysis

INVESTIGATION – The EMA covid-19 data leak, and what it tells us about mRNA instability PDF

These were some other pictures to explain some of the above papers